Skip to main content

News

SARS-CoV-2-infected cells (cell nucleus in blue, cell surface in green and viral proteins in red)

Scientists shed new light on how SARS-CoV-2 evades the immune response in early infection

19 July 2022

New study could have implications for vaccine design

Cardiff University researchers to join £20m global study to tackle cancer in children

16 June 2022

Professor Andrew Sewell and team win funding from Cancer Grand Challenge

UK researchers pioneer new virtual treatment for PTSD

15 June 2022

Online treatment ‘as effective as face-to-face therapy’, large-scale clinical trial finds

Cardiff University pays tribute to Bobi Jones as it returns to Urdd National Eisteddfod

27 May 2022

Thousands expected to attend youth festival, where the University has a busy programme of events and will sponsor the Learner’s Medal

Kidneys

School of Medicine achieves outstanding results in REF 2021

12 May 2022

The latest independent assessment of research quality across UK higher education institutions also showed that the research environment score for the School has achieved a significant rise since REF 2014

Cardiff University scientist Professor Jamie Rossjohn FRS elected to The Royal Society

Cardiff University scientist elected to The Royal Society

12 May 2022

Professor Jamie Rossjohn elected as a Fellow of the Royal Society (FRS) in recognition of his transformative contributions to science.

Scientists use vaccination to successfully treat COVID-19 for first time

21 March 2022

Jab used to treat instead of prevent disease in patient who had virus for 7.5 months

‘First-of-its-kind’ life-saving scheme is launched by Cardiff University students

10 March 2022

New scheme aims to address ‘poor’ out-of-hospital cardiac arrest survival rates in Wales

Patient and nurse

Cardiff University scientists awarded additional £10k to drive forward diagnosis of prostate cancer

13 December 2021

The research team, led by Professor Aled Clayton, are developing an exciting and innovative test to aid the diagnosis and risk assessment of prostate cancer.

First UK trial to assess use of antivirals to treat COVID-19 set to begin

9 December 2021

Cardiff University is delivering the trial with Oxford University